Why I Like Resmed (ASX: RMD) During The Ozempic Panic
Here’s why the massive de-rate of the multiple on speculation about weight loss drugs reeks of panic.
Here’s why the massive de-rate of the multiple on speculation about weight loss drugs reeks of panic.
Why did the Pro Medicus share price spike to a record of $78.85 this morning and what is the relevant news for Pro Medicus (ASX: PME)?
The EML Payments share price plunged in 2021 after the Central Bank of Ireland investigated it. So why is the EML share price up?
There are some tantalising aspects to the MedAdvisor (ASX: MDR) thesis, but is it a bit too risky?
Although the SRG Global (ASX: SRG) dividend was maintained, the second half earnings per share were a lot weaker than the first half.
The FY 2023 Laserbond results saw record earnings per share and a steady dividend, despite a lack of technology division sales.
Audinate today anounced it will raise up to $70m via a placement worth $50m and an SPP worth $20m, but the CEO sold shares 10 days ago.
The Energy One takeover offer at $5.85 may seem more attractive now that an anticipated contract has been delayed.
The mining software provider is growing its software subscription revenue and buying back shares.
The IPD Group (ASX: IPD) is up a whipping 110% in the last year, but is the easy money behind us after the FY 2023 IPD Group results?
Supply Network shares have not reacted to a strong set of FY 2023 results, probably because Supply Network profit is in line with guidance.
Energy One (ASX: EOL) shares soared 34% today in response to a takeover proposal.
Probiotic (ASX: PBP) recorded good strong revenue growth but profit and free cash flow did not follow.
Playside Studios (ASX: PLY) is not yet profitable, but it is forecasting strong revenue growth.
StepOne (ASX: STP) has a dividend yield of 9.4%, fully franked; and even subtracting that has over $28m in cash.
Alcidion’s CEO Kate Quirke says “we have a very long runway ahead of us” and “at this stage I am confident.”
The Camplify share price failed to respond to the FY 2023 Camplify results, despite very strong revenue growth and positive free cash flow.
A small beat relative to expectations sees a strong share price rise for what is undoubtedly one of the better ASX growth stocks.
Audio networking company Audinate (ASX: AD8) impressed the market with record FY 2023 results. Audinate share price up 10%.